Kiniksa Pharmaceuticals Ltd.

The momentum for this stock is not very good. Kiniksa Pharmaceuticals Ltd. has good growth characteristics. Kiniksa Pharmaceuticals Ltd. is not very popular among insiders. Kiniksa Pharmaceuticals Ltd. is a mediocre stock to choose.
Log in to see more information.
Kiniksa Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in discovering, acquiring...
KNSA Fundamental Data by TradingView

News

Los Angeles Capital Management LLC Has $1.48 Million Stock Position in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)
Los Angeles Capital Management LLC Has $1.48 Million Stock Position in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)

Zolmax Los Angeles Capital Management LLC cut its holdings in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA - Free Report) by 43.4% during the 2nd quarter, according to the company in its most recent...\n more…

Los Angeles Capital Management LLC Sells 60,650 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)
Los Angeles Capital Management LLC Sells 60,650 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)

Ticker Report Los Angeles Capital Management LLC lessened its holdings in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA - Free Report) by 43.4% during the second quarter, according to the company in its most recent...\n more…

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Insider John F. Paolini Sells 60,692 Shares
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Insider John F. Paolini Sells 60,692 Shares

Ticker Report Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA - Get Free Report) insider John F. Paolini sold 60,692 shares of the firm's stock in a transaction that occurred on Tuesday, September 3rd. The stock was...\n more…

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) COO Sells $470,925.00 in Stock
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) COO Sells $470,925.00 in Stock

Zolmax Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA - Get Free Report) COO Eben Tessari sold 17,500 shares of Kiniksa Pharmaceuticals stock in a transaction on Tuesday, August 27th. The stock was sold at an...\n more…

Peregrine Capital Management LLC Acquires 3,111 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)
Peregrine Capital Management LLC Acquires 3,111 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)

Ticker Report Peregrine Capital Management LLC increased its holdings in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA - Free Report) by 1.3% in the 2nd quarter, according to the company in its most recent Form 13F...\n more…

Eben Tessari Sells 17,500 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Stock
Eben Tessari Sells 17,500 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Stock

Ticker Report Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA - Get Free Report) COO Eben Tessari sold 17,500 shares of the stock in a transaction dated Tuesday, August 27th. The shares were sold at an average price of...\n more…